Pfizer Whistleblower Sinks Vaccine Trial Integrity

Nov 02, 2021

Sen. Johnson Holds Expert Panel On Federal Vaccine Mandates and Vaccine Injuries

www.ronjohnson.senate.gov/2021/10/media-advisory-sen-johnson-holds-expert-panel-on-federal-vaccine-mandates-and-vaccine-injuries

Dr. Peter Doshi, Associate Professor of pharmaceutical health services research at the University of Maryland School of Pharmacy

- According to a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial, data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side effects lagged way behind

- Brook Jackson was the regional director of Ventavia Research Group, a research organization charged with testing Pfizer’s COVID jab at several sites in Texas. Jackson repeatedly “informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues,” and when her concerns were ignored, she finally filed a complaint with the U.S. Food and Drug Administration

- The FDA did not follow up on her complaint. Ventavia was not one of the nine trial locations audited, and Pfizer did not bring any of those issues up when applying for emergency use authorization for its COVID shot

- Documentation shared by Jackson shows a Ventavia executive had identified three site staff members who had falsified data

- After being notified of Jackson’s complaints, Pfizer contracted Ventavia to conduct four additional trials — one for COVID shots in children and young adults, one for the COVID jab in pregnant women, a booster shot trial, and an RSV vaccine trial